Aspergillosis clinical trials at UCSF

1 research study open to eligible people

Olorofim Aspergillus Infection Study
open to eligible people ages 18 years and up
The purpose of this study is to compare treatment with olorofim versus treatment with AmBisome® followed by standard of care (SOC) in patients with IFD caused by proven IA or probable lower respiratory tract disease Aspergillus species (invasive aspergillosis, IA).
San Francisco, California and other locations

Last updated: May 2023